Blood-based prognostic biomarkers in Crohn’s Disease patients on biologics: a promising tool to predict endoscopic outcomes-Reference-Cited by-同舟云学术

Blood-based prognostic biomarkers in Crohn’s Disease patients on biologics: a promising tool to predict endoscopic outcomes

Published:2021-06-13 Issue:8 Volume:21 Page:1133-1141
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Crispino Federica¹²,Grova Mauro¹²^ORCID,Maida Marcello³,Renna Sara²,Mocciaro Filippo⁴,Casà Angelo²,Rizzuto Giulia²,Tesè Lorenzo⁵,Scimeca Daniela⁴,Di Mitri Roberto⁴,Macaluso Fabio Salvatore²,Orlando Ambrogio²

Affiliation:

1. Department of Health Promotion Sciences Maternal and Infant Care, Section of Gastroenterology & Hepatology, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Italy

2. Inflammatory Bowel Disease Unit, A.O.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy

3. Section of Gastroenterology, “S.Elia-Raimondi” Hospital, Caltanissetta, Italy

4. Gastroenterology and Endoscopy Unit, ARNAS Civico - Di Cristina - Benfratelli Hospital, Palermo,Italy

5. Radiology Unit, A.O.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy

Funder

funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1935857